Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.595 GBX | +5.57% | +0.82% | -17.72% |
2023 | Mothercare half-year profit jumps as costs fall sharper than revenue | AN |
2023 | AIM WINNERS & LOSERS: RUA Life Science slides after strong week | AN |
Strengths
- With a P/E ratio at 10.6 for the current year and 10.6 for next year, earnings multiples are highly attractive compared with competitors.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.71 for the current period. Therefore, the company is undervalued.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company does not generate enough profits, which is an alarming weak point.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Apparel & Accessories
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-17.72% | 36.85M | C | ||
+8.38% | 424B | B | ||
-29.24% | 45.59B | C | ||
+17.52% | 18.78B | A | ||
+12.32% | 10.35B | B | ||
+28.78% | 8.48B | C | ||
-10.28% | 6.32B | A- | ||
+27.92% | 6.13B | B | ||
+9.15% | 5.87B | A | ||
-11.48% | 5.76B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MTC Stock
- Ratings Mothercare plc